Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Show all lipids with this classification Show all lipids assigned to this classification.
Show only primary classification Show only those lipids which have been assigned to this class as the primary classification.
Show only secondary classifications Show only lipids which have this functionality but are not primarily assigned to this class.

Fatty Acyls [FA]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA03060106 19-HETE (5Z,8Z,11Z,14Z)-19-hydroxy-5,8,11,14-icosatetraenoic acid FA 20:4;O C20H32O3 320.235146
LMFA03060106 19-HETE (5Z,8Z,11Z,14Z)-19-hydroxy-5,8,11,14-icosatetraenoic acid FA 20:4;O C20H32O3 320.235146
LMFA05000630 4-Methyl-2-heptanol 4-methylheptan-2-ol FOH 8:0 C8H18O 130.135765
LMFA05000600 1-Hydroxy-2,12,15-heneicosatrien-4-one (2E,12E,15E)-1-hydroxyhenicosa-2,12,15-trien-4-one FOH 21:4;O C21H36O2 320.271531
LMFA01030945 (3E)-2-Propylpent-3-enoic acid (3E)-2-propylpent-3-enoic acid FA 8:1 C8H14O2 142.099380
LMFA01030945 (3E)-2-Propylpent-3-enoic acid (3E)-2-propylpent-3-enoic acid FA 8:1 C8H14O2 142.099380
LMFA01030963 2,4-dichloromuconic acid 2,4-dichlorohexa-2,4-dienedioic acid C6H4O4Cl2 209.948666
LMFA01030963 2,4-dichloromuconic acid 2,4-dichlorohexa-2,4-dienedioic acid C6H4O4Cl2 209.948666
LMFA01120005 9-NO2-CLA 9-nitro-9Z,11E-octadecadienoic acid C18H31NO4 325.225309
LMFA01120005 9-NO2-CLA 9-nitro-9Z,11E-octadecadienoic acid C18H31NO4 325.225309
LMFA01120005 9-NO2-CLA 9-nitro-9Z,11E-octadecadienoic acid C18H31NO4 325.225309
LMFA05000691 phenolic phthiocerol (3S,4R,9R,11S)-29-(4-hydroxyphenyl)-3-methoxy-4-methylnonacosane-9,11-diol FOH 37:4;O3 C37H68O4 576.511761
LMFA02000195 2R-hydroxy-stearic acid 2R-hydroxy-octadecanoic acid FA 18:0;O C18H36O3 300.266446
LMFA02000195 2R-hydroxy-stearic acid 2R-hydroxy-octadecanoic acid FA 18:0;O C18H36O3 300.266446
LMFA03140007 18S-Resolvin E3 17R,18S-dihydroxy-5Z,8Z,11Z,13E,15E-eicosapentaenoic acid FA 20:5;O2 C20H30O4 334.214411
LMFA03140007 18S-Resolvin E3 17R,18S-dihydroxy-5Z,8Z,11Z,13E,15E-eicosapentaenoic acid FA 20:5;O2 C20H30O4 334.214411
LMFA03140007 18S-Resolvin E3 17R,18S-dihydroxy-5Z,8Z,11Z,13E,15E-eicosapentaenoic acid FA 20:5;O2 C20H30O4 334.214411
LMFA07050279 9-octadecynoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-({3-[(2-{[octadec-9-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-4-oxobutyl] dihydrogen diphosphate} CoA 18:2 C39H66N7O17P3S 1029.344875
LMFA07050279 9-octadecynoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-({3-[(2-{[octadec-9-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-4-oxobutyl] dihydrogen diphosphate} CoA 18:2 C39H66N7O17P3S 1029.344875
LMFA07050279 9-octadecynoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-({3-[(2-{[octadec-9-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-4-oxobutyl] dihydrogen diphosphate} CoA 18:2 C39H66N7O17P3S 1029.344875
LMFA07050279 9-octadecynoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-({3-[(2-{[octadec-9-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-4-oxobutyl] dihydrogen diphosphate} CoA 18:2 C39H66N7O17P3S 1029.344875
LMFA07050279 9-octadecynoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-({3-[(2-{[octadec-9-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-4-oxobutyl] dihydrogen diphosphate} CoA 18:2 C39H66N7O17P3S 1029.344875
LMFA07050279 9-octadecynoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-({3-[(2-{[octadec-9-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-4-oxobutyl] dihydrogen diphosphate} CoA 18:2 C39H66N7O17P3S 1029.344875
LMFA05000648 cis-4-Decenol (4Z)-dec-4-en-1-ol FOH 10:1 C10H20O 156.151415
LMFA07070071 Hydroxybutyrylcarnitine (3S)-3-[(3-hydroxybutanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 4:0;O C11H21NO5 247.141974
LMFA07070071 Hydroxybutyrylcarnitine (3S)-3-[(3-hydroxybutanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 4:0;O C11H21NO5 247.141974
LMFA07010740 2-Propenyl 2,4-hexadienoate prop-2-en-1-yl (2E,4E)-hexa-2,4-dienoate WE 9:3 C9H12O2 152.083730
LMFA07010740 2-Propenyl 2,4-hexadienoate prop-2-en-1-yl (2E,4E)-hexa-2,4-dienoate WE 9:3 C9H12O2 152.083730
LMFA05000569 (Z)-2-Decene-4,6,8-triyn-1-ol (2E)-dec-2-en-4,6,8-triyn-1-ol FOH 10:7 C10H8O 144.057515
LMFA08020201 pre-putrebactin 4-{[4-({4-[(4-aminobutyl)(hydroxy)amino]-4-oxobutanoyl}amino)butyl](hydroxy)amino}-4-oxobutanoic acid C16H30N4O7 390.211450
LMFA07070097 O-palmitoleoylcarnitine 3-[(9Z)-hexadec-9-enoyloxy]-4-(trimethylazaniumyl)butanoate CAR 16:1 C23H43NO4 397.319209
LMFA07070097 O-palmitoleoylcarnitine 3-[(9Z)-hexadec-9-enoyloxy]-4-(trimethylazaniumyl)butanoate CAR 16:1 C23H43NO4 397.319209
LMFA07070045 3-hydroxytetradecanoylcarnitine 3-[(3-hydroxytetradecanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 14:0;O C21H41NO5 387.298474
LMFA07070045 3-hydroxytetradecanoylcarnitine 3-[(3-hydroxytetradecanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 14:0;O C21H41NO5 387.298474
LMFA07070076 Isovalerylcarnitine 3-[(3-methylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 5:0 C12H23NO4 245.162709
LMFA07070076 Isovalerylcarnitine 3-[(3-methylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 5:0 C12H23NO4 245.162709
LMFA07010746 2-Propenyl heptanoate prop-2-en-1-yl heptanoate WE 10:1 C10H18O2 170.130680
LMFA07010746 2-Propenyl heptanoate prop-2-en-1-yl heptanoate WE 10:1 C10H18O2 170.130680
LMFA07010694 (+/-)-Ethyl 2-hydroxy-3-methylvalerate ethyl 2-hydroxy-3-methylpentanoate SFE 8:0;O C8H16O3 160.109945
LMFA07010694 (+/-)-Ethyl 2-hydroxy-3-methylvalerate ethyl 2-hydroxy-3-methylpentanoate SFE 8:0;O C8H16O3 160.109945
LMFA07010694 (+/-)-Ethyl 2-hydroxy-3-methylvalerate ethyl 2-hydroxy-3-methylpentanoate SFE 8:0;O C8H16O3 160.109945
LMFA08020179 gamma-sanshool N-(2-methylpropyl)tetradeca-2E,4E,8Z,10E,12E-pentaenamide NA 18:5 C18H27NO 273.209264
LMFA08020179 gamma-sanshool N-(2-methylpropyl)tetradeca-2E,4E,8Z,10E,12E-pentaenamide NA 18:5 C18H27NO 273.209264
LMFA08020179 gamma-sanshool N-(2-methylpropyl)tetradeca-2E,4E,8Z,10E,12E-pentaenamide NA 18:5 C18H27NO 273.209264
LMFA07010788 Ascorbyl palmitate 2-(3,4-dihydroxy-5-oxo-2,5-dihydrofuran-2-yl)-2-hydroxyethyl hexadecanoate WE 22:3;O5 C22H38O7 414.261756
LMFA07010788 Ascorbyl palmitate 2-(3,4-dihydroxy-5-oxo-2,5-dihydrofuran-2-yl)-2-hydroxyethyl hexadecanoate WE 22:3;O5 C22H38O7 414.261756
LMFA07010788 Ascorbyl palmitate 2-(3,4-dihydroxy-5-oxo-2,5-dihydrofuran-2-yl)-2-hydroxyethyl hexadecanoate WE 22:3;O5 C22H38O7 414.261756
LMFA07050237 3-oxoadipyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(5-carboxy-3-oxopentanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 6:2;O3 C27H42N7O20P3S 909.141819
LMFA07050237 3-oxoadipyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(5-carboxy-3-oxopentanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 6:2;O3 C27H42N7O20P3S 909.141819
LMFA07050237 3-oxoadipyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(5-carboxy-3-oxopentanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 6:2;O3 C27H42N7O20P3S 909.141819